Cargando…

Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy

To reveal the correlation of dynamic serum tumor markers (STMs) and molecular features of epidermal growth factor receptor‐mutated (EGFR‐mutated) lung cancer during targeted therapy, we retrospectively reviewed 303 lung cancer patients who underwent dynamic STM tests [neuron‐specific enolase (NSE),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhuxing, Liu, Liping, Zhu, Feng, Cai, Xiuyu, Zhao, Yi, Liang, Peng, Ou, Limin, Zhong, Ran, Yu, Ziwen, Li, Caichen, Li, Jianfu, Xiong, Shan, Feng, Yi, Cheng, Bo, Liang, Hengrui, Xie, Zhanhong, Liang, Wenhua, He, Jianxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385589/ https://www.ncbi.nlm.nih.gov/pubmed/35543090 http://dx.doi.org/10.1002/cam4.4676

Ejemplares similares

Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database
por: Xiong, Shan, et al.
Publicado: (2023)

The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
por: Li, Feng, et al.
Publicado: (2021)

Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
por: He, Qihua, et al.
Publicado: (2021)

Management for Residual Ground-Glass Opacity Lesions After Resection of Main Tumor in Multifocal Lung Cancer: A Case Report and Literature Review
por: Cheng, Bo, et al.
Publicado: (2021)

Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
por: Liang, Hengrui, et al.
Publicado: (2020)

The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer
por: Cheng, Bo, et al.
Publicado: (2021)

Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report
por: Chen, Zhuxing, et al.
Publicado: (2021)

Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
por: Li, Caichen, et al.
Publicado: (2020)

An annual review of the remarkable advances in lung cancer clinical research in 2019
por: Cheng, Bo, et al.
Publicado: (2020)

Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers
por: Deng, Hongsheng, et al.
Publicado: (2022)

Concealed driver in lung adenocarcinoma with single PIK3CA mutation: a case report and single-center genotyping review
por: Zhu, Feng, et al.
Publicado: (2021)

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations
por: Jiang, Yu, et al.
Publicado: (2023)

DNA methylation markers that correlate with occult lymph node metastases of non-small cell lung cancer and a preliminary prediction model
por: Chen, Zisheng, et al.
Publicado: (2020)

“Major pathologic response” in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy
por: Deng, Hongsheng, et al.
Publicado: (2023)

Lung cancers and pulmonary nodules detected by computed tomography scan: a population-level analysis of screening cohorts
por: Li, Caichen, et al.
Publicado: (2021)

PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China
por: Li, Caichen, et al.
Publicado: (2020)

Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer
por: Zhu, Feng, et al.
Publicado: (2023)

Identifying optimal candidates for primary tumor resection among metastatic non-small cell lung cancer patients: a population-based predictive model
por: Liang, Hengrui, et al.
Publicado: (2021)

Prognostic and predictive impact of creatine kinase level in non-small cell lung cancer treated with tyrosine kinase inhibitors
por: Jiang, Yu, et al.
Publicado: (2021)

Thoracic surgery and COVID-19: changes and managements during the pandemic
por: Wang, Runchen, et al.
Publicado: (2021)

Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study
por: Feng, Yi, et al.
Publicado: (2022)

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
por: Liang, Wenhua, et al.
Publicado: (2020)

Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer
por: Ou, Limin, et al.
Publicado: (2023)

Association between certain non–small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death‐ligand 1 inhibition
por: Liang, Wenhua, et al.
Publicado: (2019)

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer
por: He, Miao, et al.
Publicado: (2023)

Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer
por: Zheng, Jianqi, et al.
Publicado: (2021)

Association between systemic lupus erythematosus and lung cancer: results from a pool of cohort studies and Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2020)

Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer
por: Wu, Xiangrong, et al.
Publicado: (2022)

Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2022)

Nomogram for predicting the survival rate of primary pulmonary mucoepidermoid carcinoma patients: a retrospective study based on SEER database
por: Lin, Guo, et al.
Publicado: (2021)

Inhaled corticosteroids and risk of lung cancer among chronic obstructive pulmonary disease patients: a comprehensive analysis of nine prospective cohorts
por: Ge, Fan, et al.
Publicado: (2021)

Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts
por: Ge, Fan, et al.
Publicado: (2020)

No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
por: Li, Feng, et al.
Publicado: (2021)

Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis
por: Liang, Hengrui, et al.
Publicado: (2020)

Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis
por: Zhao, Yi, et al.
Publicado: (2019)

Aspirin and risk of different cancers: an umbrella meta-analysis
por: Jiang, Yu, et al.
Publicado: (2020)

Univariable and Multivariable Two-Sample Mendelian Randomization Investigating the Effects of Leisure Sedentary Behaviors on the Risk of Lung Cancer
por: Peng, Haoxin, et al.
Publicado: (2021)

Genetically predicted bipolar disorder is causally associated with an increased risk of breast cancer: a two-sample Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2021)

Age at first birth and lung cancer: a two-sample Mendelian randomization study
por: Peng, Haoxin, et al.
Publicado: (2021)

Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer: A Systematic Review and Meta-analysis
por: Ge, Fan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usn2g852tnt3jatsmfgbm4pt74